Search our site
Submit Search
Submit search
News
Opinion
Preferred Vendors
Jobs
Training
Contact Us
Member Login
Member Login
Search
Submit Search
Submit search
Click to close Menu
About ACAP
Who We Serve
Our Plans
About Safety Net Health Plans
Board of Directors / Membership Council
Staff
How to become a member
Awards
Policy & Advocacy
Research & Best Practices
Events
Plan Resources
Discussion Board
Click to search site
Click to open menu
policy
Comment Letter
Quality
Response to Senate Finance Committee on High-Cost Breakthrough Drugs
Actuarial Soundness
,
Costs
,
High-Cost Drugs
,
Pharmacy
,
Rate Setting
,
State and Federal Policy
View the full article »
Related Articles
ACAP Research
Coronavirus
The Importance of Maintaining Actuarial Soundness During COVID-19
September 29, 2021
ACAP Research
Marketplaces
Overlap Issuers: Possible Drivers of Premium Reductions: June 2020
June 25, 2020
Comment Letter
Prescription Drugs
PQA Comment Letter: Medicare and Medicaid Programs Contract Year 2021 and 2022
April 15, 2020
Plan Resource
Coronavirus
COVID-19 – Brief Advice from Plan Leaders
April 6, 2020
Comment Letter
Continuous Eligibility
Stakeholder Letter in Response to RFI on Maternal Health
April 6, 2020
Comment Letter
Coronavirus
Sign-On Letter to President Trump: Invoke Defense Production Act to Save Lives
April 3, 2020
